Earnings History Data for Oyster Point Pharma, Inc. (OYST) - NYSE NASDAQ

To lookup another company type a stock symbol and press 'Go'. The overview will show the earnings release info that is available in TheStockCatalyst database for the company.

For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.

See the full list of available companies here.

Oyster Point Pharma, Inc.

Oyster Point Pharma Inc. is a clinical-stage biopharmaceutical company. It is focused on the discovery, development and commercialization of pharmaceutical therapies to treat ocular surface diseases. The company's lead product candidate, OC-01, is being developed as a nasal spray to treat the signs and symptoms of dry eye disease. Oyster Point Pharma Inc. is based in Princeton, New Jersey.

Release Date	Time	Est. Time	Symbol	Name	Market Cap (M)	Rep. EPS	Est. EPS	Last years EPS	SeekingAlpha Headline	Price	Change	Ext. Hours Price	Ext. Hours Change	52 Week Range	Volume	Avg. Volume	Ext. Hours Volume
10-11-2022	AH	4:00 PM ET (Nov 10)	OYST	Oyster Point Pharma, Inc.	310.98	-1.37	-1.51	-0.68		11.19	-0.35 (-3.03%)	11.17	-0.37 (-3.21%)	3.46 - 19.98	464,525	1,320,000	24,596
Oyster Point Pharma Reports Third Quarter 2022 Financial Results and Recent Business Highlights [Nov-10-22 04:05PM]
11-08-2022	AH	4:00 PM ET (Aug 11)	OYST	Oyster Point Pharma, Inc.	161.88	-1.87	-1.64	-0.85		7.00	-0.96 (-12.03%)	7.99	0.03 (0.38%)	3.46 - 19.98	255,871	130,000	1,090

24-02-2022	AH	4:05 PM ET (Feb 24)	OYST	Oyster Point Pharma, Inc.	260.59	-1.61	-1.39	-0.86	Oyster Point Pharma Non-GAAP EPS of -$1.61 misses by $0.23, revenue of $6.59M beats by $6.29M [2/24/2022 4:33 PM]	11.00	-0.29 (-2.57%)	11.29	0.0 (0.00%)	9.24 - 23.18	102,171	240,000	160
Oyster Point Pharma Non-GAAP EPS of -$1.61 misses by $0.23, revenue of $6.59M beats by $6.29M [2/24/2022 4:33 PM] Oyster Point Pharma Reports Fourth Quarter and Full Year 2021 Financial Results and Recent Business Highlights [Feb-24-22 04:01PM] Oyster Point Pharma, Inc. (OYST) Q4 2021 Earnings Call Transcript [Feb-25-22 02:30AM]
04-11-2021	AH	4:00 PM ET (Nov 4)	OYST	Oyster Point Pharma, Inc.	327.00	-0.68	-1.16	-0.63	Oyster Point Pharma EPS beats by $0.48 [11/4/2021 5:43 PM]	14.10	0.69 (5.15%)	13.86	0.45 (3.36%)	10.00 - 25.89	448,949	320,000	4,702
Oyster Point Pharma EPS beats by $0.48 [11/4/2021 5:43 PM] Oyster Point Pharmas TYRVAYA (varenicline solution) Nasal Spray is Now Available at U.S. Regional Wholesalers for Distribution to Pharmacies for the Treatment of the Signs and Symptoms of Dry Eye Disease [Nov-03-21 04:05PM] Oyster Point Pharma Announces Patient Savings Program Where Eligible Patients Can Pay as Little as $0 for TYRVAYA (varenicline solution) Nasal Spray for the Treatment of The Signs and Symptoms of Dry Eye Disease [Nov-04-21 08:00AM] Oyster Point Pharma Reports Third Quarter 2021 Financial Results and Recent Business Highlights [Nov-04-21 04:05PM]
05-08-2021	AH	4:00 PM ET (Aug 5)	OYST	Oyster Point Pharma, Inc.	366.55	-0.85	-0.85	-0.66	Oyster Point Pharma EPS in-line [8/5/2021 4:08 PM]	14.62	0.17 (1.18%)	14.45	0.0 (0.00%)	13.50 - 27.93	56,588	110,000	282
Oyster Point Pharma to Report Second Quarter 2021 Financial Results on August 5, 2021 [Aug-04-21 08:30AM] Oyster Point Pharma Reports Second Quarter 2021 Financial Results and Recent Business Highlights [Aug-05-21 04:02PM] Oyster Point Pharma Announces Exclusive License Agreement with Ji Xing Pharmaceuticals to Develop and Commercialize OC-01 and OC-02 in Greater China [Aug-05-21 04:01PM] Oyster Point Pharma, Inc. (OYST) Q2 2021 Earnings Call Transcript [Aug-05-21 10:31PM] Oyster Point Inks License Pact With Ji Xing Pharma For Dry Eye Disease Candidates In Greater China [Aug-06-21 10:12AM]
06-05-2021	AH	4:00 PM ET (May 6)	OYST	Oyster Point Pharma, Inc.	509.38	-0.73	-0.91	-0.77	Oyster Point Pharma EPS beats by $0.18 [5/6/2021 4:04 PM]	17.78	-0.06 (-0.34%)	0.0	0.0 (0.00%)	16.70 - 35.97	63,105	40,000	0
Oyster Point Pharma EPS beats by $0.18 [5/6/2021 4:04 PM] New Strong Sell Stocks for May 6th [May-06-21 09:18AM] Oyster Point Pharma Inc to Host Earnings Call [May-06-21 02:45PM] Oyster Point Pharma Reports First Quarter 2021 Financial Results and Recent Business Highlights [May-06-21 04:01PM] Oyster Point Pharma, Inc. (OYST) Q1 2021 Earnings Call Transcript [May-07-21 09:01AM]
18-02-2021	AH	4:00 PM ET (Feb 18)	OYST	Oyster Point Pharma, Inc.	636.10	-0.86	-0.79	-1.41	Oyster Point Pharma EPS misses by $0.07 [2/18/2021 4:12 PM]	22.96	-2.63 (-10.28%)	25.86	0.0 (0.00%)	17.24 - 41.37	116,051	118,827	190
Oyster Point Pharma EPS misses by $0.07 [2/18/2021 4:12 PM] Oyster Point Pharma Reports Fourth Quarter and Full Year 2020 Financial Results and Recent Business Highlights [Feb-18-21 04:01PM]
05-11-2020	AH	4:00 PM ET (Nov 5)	OYST	Oyster Point Pharma, Inc.	569.91	-0.63	-0.74	-8.10	Oyster Point Pharma EPS beats by $0.11 [11/5/2020 5:15 PM]	22.75	-0.22 (-0.96%)	22.49	0.0 (0.00%)	13.26 - 41.37	37,848	51,149	2,027

05-08-2020	PM	6:00 AM ET (Aug 5)	OYST	Oyster Point Pharma, Inc.	574.74	-0.66	-0.81	0.00	Oyster Point Pharma EPS beats by $0.15 [8/5/2020 7:14 AM]	27.54	3.06 (12.50%)	0.0	0.0 (0.00%)	13.26 - 41.37	66,356	56,910	0